Citations
240 citation(s) found for "Begna, Kebede".
Molecular Predictors of Response and Survival in Patients with Relapsed/Refractory Acute Myeloid Leukemia Following Venetoclax Plus Hypomethylating Agent Therapy
Johnson, Isla McKerrow , Ilyas, Rimal, Al‐Kali, Aref , Begna, Kebede H. , Mangaonkar, Abhishek A. , Litzow, Mark R. , Patnaik, Mrinal M. , Pardanani, Animesh , Tefferi, Ayalew , Gangat, Naseema , McCullough, Kristen , Alkhateeb, Hassan B. , Hogan, William J. , Shah, Meera
Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 3233-3234
Characteristics and Outcomes of Patients with BCOR Mutated Myeloid Neoplasms
Barua, Amit , Yıkılmaz, Aysun Şentürk , He, Rong , Viswanatha, David S., Katamesh, Bahga , Mangaonkar, Abhishek A. , Gangat, Naseema , Patnaik, Mrinal M. , Litzow, Mark R. , Begna, Kebede H. , Tefferi, Ayalew , Al‐Kali, Aref , Baranwal, Anmol , Shah, Meera , Badar, Talha , Hogan, William J. , Alkhateeb, Hassan B.
Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 3235-3236
Determinants of Survival and Retrospective Comparisons in 183 Clinical Trial Patients with Myelofibrosis Treated with Ruxolitinib, Fedratinib, Momelotinib, or BMS-911543 JAK2 Inhibitor between 2007 and 2013
Gangat, Naseema , Begna, Kebede H. , Al‐Kali, Aref , Litzow, Mark R. , Pardanani, Animesh , Tefferi, Ayalew , Hogan, William J.
Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 3945-3946
Therapy-Related Myelodysplastic Syndromes with Isolated Del(5q): Comparative Analysis of Phenotype and Long-Term Survival
Fleti, Farah, Singh, Amritpal , Al‐Kali, Aref , Foran, James M. , Elliott, Michelle A. , Begna, Kebede H. , Khera, Nandita , Abdelmagid, Maymona, Reichard, Kaaren K. , Pardanani, Animesh , Gangat, Naseema , Tefferi, Ayalew , Badar, Talha , Shah, Meera , Alkhateeb, Hassan B. , Ketterling, Rhett P.
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 6940-6941
Predictors of Response to Venetoclax Plus Hypomethylating Agent Therapy and Survival in Blast-Phase Myeloproliferative Neoplasm
Gangat, Naseema , Ilyas, Rimal, Begna, Kebede H. , Al‐Kali, Aref , Patnaik, Mrinal M. , Litzow, Mark R. , Mangaonkar, Abhishek A. , Elliott, Michelle A. , Foran, James M. , Palmer, Jeanne , Hanson, Curtis A. , Pardanani, Animesh , Tefferi, Ayalew , McCullough, Kristen , Hogan, William J. , Alkhateeb, Hassan B. , Shah, Meera , Badar, Talha
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9675-9676
Clinical and Genetic Characteristics of STAG2 Mutations in Myeloid Neoplasms
Katamesh, Bahga , Nanaa, Ahmad , He, Rong , Viswanatha, David S., Nguyen, Phuong L., Bessonen, Kurt, Gangat, Naseema , Begna, Kebede H. , Mangaonkar, Abhishek A. , Patnaik, Mrinal M. , Tefferi, Ayalew , Litzow, Mark R. , Foran, James M. , Al‐Kali, Aref , Greipp, Patricia T. , Hogan, William J. , Shah, Meera , Yi, Cecilia Arana , Badar, Talha , Alkhateeb, Hassan B.
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 12353-12354
Reappraisal of Mast Cell Leukemia Based on a Single Institution Review of 16 Cases: Role of Mast Cell Morphology in Determining Clinical Outcome
Pardanani, Animesh , Tefferi, Ayalew , Singh, Amritpal , Al‐Kali, Aref , Patnaik, Mrinal M. , Begna, Kebede, Elliott, Michelle A. , Khera, Nandita , Palmer, Jeanne , Gangat, Naseema , Kelemen, Katalin, Reichard, Kaaren K. , Hogan, William J. , Orazi, Attilio , Chen, Dong
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 6872-6873
TP53 Mutation Status Defines a Distinct Clinicopathological Entity of Therapy-Related Myeloid Neoplasm, Characterized By Genomic Instability and Extremely Poor Outcome
Sharplin, Kirsty, Chhetri, Rakchha , Ladon, Dariusz, Al‐Kali, Aref , Litzow, Mark R. , Mangaonkar, Abhishek A. , Gangat, Naseema , Patnaik, Mrinal M. , Begna, Kebede, Tefferi, Ayalew , Shah, Meera , Hahn, Christopher N , Tran, Elizabeth Ngoc Hoa , Baranwal, Anmol , Kutyna, Monika , Wang, Paul Po-Shen , Alkhateeb, Hassan B. , Ross, David M , Yeung, David , Shanmuganathan, Naranie , Hogan, William J. , Kumar, Sharad , Singhal, Deepak , Brown, Anna , Scott, Hamish S. , THOMAS, DANIEL W. , Kok, Chung Hoow , Hiwase, Devendra
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9798-9799
Clonal Hematopoiesis in Vexas Syndrome
Gutierrez‐Rodrigues, Fernanda , Kusne, Yael , Fernandez, Jenna A., Ma, Xiaoyang , Alessi, Hugh, Finke, Christy M. , Mangaonkar, Abhishek A. , Begna, Kebede H. , Viswanatha, David S., Wilson, Lorena, Kourelis, Taxiarchis , Reichard, Kaaren K. , Olteanu, Horatiu , Darden, Ivana, Hironaka, Dalton, Rosenzweig, Sofia , Kastner, Daniel L. , Grayson, Peter C. , Beck, David B. , Patnaik, Mrinal M. , Young, Neal S. , Patel, Bhavisha A. , Lasho, Terra L. , Shalhoub, Ruba N. , Koster, Matthew J. , Warrington, Kenneth J. , Xie, Zhuoer , Ombrello, Amanda K. , Ferrada, Marcela A. , Go, Ronald S. , Groarke, Emma M , Calvo, Katherine R. , Wu, Colin O.
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 5745-5746
Venetoclax Plus Hypomethylating Agent (HMA) Based Induction for Treatment-Naive Older/Unfit Patients with FLT3-Mutated Acute Myeloid Leukemia (AML)
Ghorab, Ahmad , Litzow, Mark R. , Gangat, Naseema , Al‐Kali, Aref , Tefferi, Ayalew , Begna, Kebede H. , Patnaik, Mrinal M. , Foran, James M. , Ghorab, Ahmad , Shah, Meera , Murthy, Hemant S. , Alkhateeb, Hassan B. , Badar, Talha
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9019-9020